129 related articles for article (PubMed ID: 32519453)
1. Core-Shell-Satellite Nanomaces as Remotely Controlled Self-Fueling Fenton Reagents for Imaging-Guided Triple-Negative Breast Cancer-Specific Therapy.
Du Y; Yang C; Li F; Liao H; Chen Z; Lin P; Wang N; Zhou Y; Lee JY; Ding Q; Ling D
Small; 2020 Aug; 16(31):e2002537. PubMed ID: 32519453
[TBL] [Abstract][Full Text] [Related]
2. Au-Fe
Wei R; Fu G; Li Z; Liu Y; Qi L; Liu K; Zhao Z; Xue M
J Colloid Interface Sci; 2024 Jun; 663():644-655. PubMed ID: 38430834
[TBL] [Abstract][Full Text] [Related]
3. Photothermal Ferrotherapy - Induced Immunogenic Cell Death via Iron-Based Ternary Chalcogenide Nanoparticles Against Triple-Negative Breast Cancer.
Wu Q; Li Z; Zhou X; Wei Z; Ramadan S; Xu Y; Xu L; Li D
Small; 2024 May; 20(20):e2306766. PubMed ID: 38095479
[TBL] [Abstract][Full Text] [Related]
4. Near-Infrared Phototheranostic Iron Pyrite Nanocrystals Simultaneously Induce Dual Cell Death Pathways via Enhanced Fenton Reactions in Triple-Negative Breast Cancer.
Zhao C; Liu Z; Chang CC; Chen YC; Zhang Q; Zhang XD; Andreou C; Pang J; Liu ZX; Wang DY; Kircher MF; Yang J
ACS Nano; 2023 Mar; 17(5):4261-4278. PubMed ID: 36706095
[TBL] [Abstract][Full Text] [Related]
5. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer.
Zhang M; Kim HS; Jin T; Moon WK
J Photochem Photobiol B; 2017 May; 170():58-64. PubMed ID: 28390259
[TBL] [Abstract][Full Text] [Related]
7. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide.
Knickle A; Fernando W; Greenshields AL; Rupasinghe HPV; Hoskin DW
Food Chem Toxicol; 2018 Aug; 118():154-167. PubMed ID: 29742465
[TBL] [Abstract][Full Text] [Related]
8. "Double-punch" strategy against triple-negative breast cancer via a synergistic therapy of magneto-mechanical force enhancing NIR-II hypothermal ablation.
Du H; Yang F; Yao C; Lv W; Peng H; Stanciu SG; Stenmark HA; Song YM; Jiang B; Wu A
Biomaterials; 2022 Dec; 291():121868. PubMed ID: 36332286
[TBL] [Abstract][Full Text] [Related]
9. ZD2-Engineered Gold Nanostar@Metal-Organic Framework Nanoprobes for T
Zhang L; Liu C; Gao Y; Li Z; Xing J; Ren W; Zhang L; Li A; Lu G; Wu A; Zeng L
Adv Healthc Mater; 2018 Dec; 7(24):e1801144. PubMed ID: 30370656
[TBL] [Abstract][Full Text] [Related]
10. Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy.
Nguyen NT; Kim J; Le XT; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
ACS Nano; 2023 Jan; 17(1):382-401. PubMed ID: 36579941
[TBL] [Abstract][Full Text] [Related]
11. Supramolecular magnetonanohybrids for multimodal targeted therapy of triple-negative breast cancer cells.
Mansur AAP; Mansur HS; Leonel AG; Carvalho IC; Lage MCG; Carvalho SM; Krambrock K; Lobato ZIP
J Mater Chem B; 2020 Aug; 8(32):7166-7188. PubMed ID: 32614035
[TBL] [Abstract][Full Text] [Related]
12. IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer.
Valcourt DM; Dang MN; Day ES
J Biomed Mater Res A; 2019 Aug; 107(8):1702-1712. PubMed ID: 30920169
[TBL] [Abstract][Full Text] [Related]
13. Fenton-reaction-stimulative nanoparticles decorated with a reactive-oxygen-species (ROS)-responsive molecular switch for ROS amplification and triple negative breast cancer therapy.
Zhang J; Zuo T; Liang X; Xu Y; Yang Y; Fang T; Li J; Chen D; Shen Q
J Mater Chem B; 2019 Dec; 7(45):7141-7151. PubMed ID: 31663577
[TBL] [Abstract][Full Text] [Related]
14. Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy.
Vaidya AM; Sun Z; Ayat N; Schilb A; Liu X; Jiang H; Sun D; Scheidt J; Qian V; He S; Gilmore H; Schiemann WP; Lu ZR
Bioconjug Chem; 2019 Mar; 30(3):907-919. PubMed ID: 30739442
[TBL] [Abstract][Full Text] [Related]
15. Fe
Wu H; Cheng K; He Y; Li Z; Su H; Zhang X; Sun Y; Shi W; Ge D
ACS Biomater Sci Eng; 2019 Feb; 5(2):1045-1056. PubMed ID: 33405795
[TBL] [Abstract][Full Text] [Related]
16. Tuning the Distance of Rattle-Shaped IONP@Shell-in-Shell Nanoparticles for Magnetically-Targeted Photothermal Therapy in the Second Near-Infrared Window.
Tsai MF; Hsu C; Yeh CS; Hsiao YJ; Su CH; Wang LF
ACS Appl Mater Interfaces; 2018 Jan; 10(2):1508-1519. PubMed ID: 29200260
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin-Targeting and Cathepsin B-Activatable Theranostic Nanoprobe for MR/Fluorescence Imaging and Enhanced Photodynamic Therapy for Triple Negative Breast Cancer.
Wang Y; Jiang L; Zhang Y; Lu Y; Li J; Wang H; Yao D; Wang D
ACS Appl Mater Interfaces; 2020 Jul; 12(30):33564-33574. PubMed ID: 32633941
[TBL] [Abstract][Full Text] [Related]
18. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
[TBL] [Abstract][Full Text] [Related]
19. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
[TBL] [Abstract][Full Text] [Related]
20. Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity.
Fultang N; Illendula A; Chen B; Wu C; Jonnalagadda S; Baird N; Klase Z; Peethambaran B
PLoS One; 2019; 14(5):e0217789. PubMed ID: 31150511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
